Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue and/or fever

Details for Australian Patent Application No. 2009323008 (hide)

Owner Alder Biopharmaceuticals, Inc.

Inventors Smith, Jeffrey T. L.; Schatzman, Randall C.; Litton, Mark; Latham, John

Agent Watermark

Pub. Number AU-A-2009323008

PCT Pub. Number WO2010/065078

Priority 12/391,615 24.02.09 US; 61/117,839 25.11.08 US; 61/117,861 25.11.08 US; 12/391,717 24.02.09 US; 12/366,567 05.02.09 US; 12/399,156 06.03.09 US; 61/117,811 25.11.08 US; 12/502,581 14.07.09 US

Filing date 24 November 2009

Wipo publication date 10 June 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/065078 Priority application(s): WO2010/065078

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009323009-Antibodies to IL-6 and use thereof

2009323007-Antagonists of IL-6 to prevent or treat thrombosis